drugset / Trial / NCT00730418

Effects of Chronic Use of Doxazosin in Men With Benign Prostatic Hyperplasia

NCT00730418

Completed 25 enrolled Samsung Medical Center
Non-randomizedParallel-groupOpen-labelBasic science

Summary

In this study, we investigate the changes of the expression of alpha adrenergic receptor in the prostate tissue during 2-yr medication period in the man with benign prostatic hyperplasia. And we also evaluate the efficacy and safety of 24 mo-treatment with doxazosin (4mg, 8mg)

Timeline

Start
2007-01
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxazosin Small molecule 4 mg
Subject Doxazosin Small molecule 8 mg